Long-Term Efficacy of Brodalumab for the Treatment of Moderate-to-Severe Psoriasis: Data from a Pivotal Phase 3 Clinical Trial. J of Skin 2018, 2 (S1), S9. https://doi.org/10.25251/skin.2.supp.9.